Abbott's Stent Gets Panel Nod, OPXA Awaits Data In Q4, It's A Yes For SPPI

Spectrum Pharmaceuticals' (SPPI) multiple myeloma treatment Evomela, which was denied approval last October, has been green lighted by the FDA in its second go-around.

from RTT - Biotech http://ift.tt/1pni6Na
via IFTTT